-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Monthly Archives: February 2011
BIO Comments to USTR on 2011 Special 301 Review
BIO Comments to USTR on 2011 Special 301 Review (February 15, 2011) In comments to the U.S. Trade Representative (USTR), BIO stresses the critical importance of protecting intellectual property abroad and made recommendations about which countries to include on the Priority Watch and Watch List, which to elevate as a Priority Foreigh Country, and which countries to monitor. Read the Comments (link to http://bio.org/pdfs/BIO_2011_Special_301_Submission.pdf) Read the Press Release (link to http://bio.org/news/pressreleases/newsitem.asp?id=2011_0221_01)
World’s Farmers Favor Biotech Crops
Because of its contribution to agricultural productivity and sustainable farming, growers around the world continue to choose biotech crop varieties according to a report released today by the International Service for the Acquisition of Agri-Biotech Applications (ISAAA). The ISAAA report, Global Status of Commercialized Biotech/GM Crops: 2010, says a record 15.4 million farmers in 29 countries are growing biotech crops on 366 million acres. According to the report’s executive summary, a record 87-fold increase in Read More >
Don’t Panic Over Biotech Alfalfa
The Atlantic published a piece authored by James McWilliams, Associate Professor of history at Texas State University and author of Just Food: Where Locavores Get It Wrong and How We Can Truly Eat Responsibly. The USDA’s recent decision to (re)deregulate genetically modified (GM) alfalfa has sent a shock wave of panic through the organic foods industry because organic farmers (who produce between .5 and 1 percent of the nation’s alfalfa) believe their product could be Read More >
AAAS Meeting to Feature Session on GM Crop Regulations
The American Association for the Advancement of Science (AAAS) will hold its annual meeting in Washington, D.C. this week, February 17-21, hosting nearly 8,000 attendees for symposia, lectures, seminars, workshops, and poster sessions that cover every area of science, technology, and education. A symposium titled “GM Crop Regulations: Safety Net or Insurmountable Obstacle?” will be presented on Friday, February 18. This session will address the two prime reasons why fresh market and specialty GM foodstuffs Read More >
2011, The Year of Positive Thinking? BIO/IPREO Study Reveals High Hopes for the Industry
BIO CEO’s closing plenary session featured plenty of crystal ball gazing and candid quips about what 2011 has in store for the biotech industry. While the panel provided an in-depth look at how buy-side and sell-side analysts evaluate the industry, the BIO/IPREO Investor Perception Study reveals that the majority of investors believe biotech is headed in the right direction. Access full study deck here: BIO CEO – IPREO Biotech Investor Perception Study The study also reveals that Read More >
